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Salivary Diagnostics in Oral 
Diseases
Manohar Bhat and Devikripa Bhat
Abstract
Common oral diseases like dental caries, periodontal diseases and oral cancer 
have major impact on quality of life. For prevention, treatment and prognosis, it is 
essential to measure the disease objectively and accurately in a quantitative manner. 
Quantification of biochemical or molecular specific products of cancers in serum or 
localized body juices can be one of the current methods of measuring oral diseases 
objectively. Salivary diagnostics has influenced several researchers and has been veri-
fied as an important tool in the diagnosis of many systemic conditions and prognosis 
of the disease. Developments in the field of molecular biology, salivary genomics and 
proteomics have directed to the detection of novel molecular markers for oral disease 
diagnosis, therapeutics and prognosis.
Keywords: oral malignant disorders, dental caries, periodontal disease
1. Introduction
Early diagnosis of the disease, quantification of the disease and prognosis of 
the treatment are the vital steps in controlling and preventing the diseases that 
would damage the person’s quality of life. Diagnosing these diseased conditions 
has become challenging and thus necessitates complementing clinical evaluation 
with laboratory testing [1]. It is essential to have a thorough knowledge in order to 
control or prevent a disease. When we know the particular clinical, radiological, 
and histological and laboratory characteristics of the disease, it is easy to prevent 
the disease condition.
Chronic non-communicable diseases are the major public health problems faced 
by many of the developed and developing countries in the world. Unlike most of the 
communicable diseases, chronic non-communicable diseases are initiated by mul-
tiple risk-factors. Identifying such risk factors is vital to control the disease burden. 
Identifying unique compound in the diseased body, which is sensitive and specific 
to that particular disease can help in identifying and measuring the disease status.
2. Why saliva is used for diagnosis?
Saliva was used as a screening tool for cystic fibrosis in the early 1960s [2, 3]. Saliva 
is the exudate of serum; hence saliva also contains all the biological compounds like 
hormones, growth factors, antibodies, enzymes, microbes and their products [2, 4, 5]. 
Salivary diagnostics has become popular these days as collecting saliva is non-invasive, 
inexpensive, less technique sensitive and easy to perform as compared to serum.
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3. Oral diseases
3.1 Dental caries and saliva
Dental caries is a multifactorial oral disease resulting in demineralization of 
mineralised tissues and denaturation of organic tissues of the teeth initiated by acid 
production by cariogenic bacteria. These are the major reasons for the loss of teeth 
among the population. Saliva has protective action in maintaining oral health by its 
buffering action, antibacterial action and cleansing effect. The awareness of func-
tional properties of saliva as well as those of its distinct components may permit a 
better valuation of dental caries susceptibility [6].
4. Caries susceptible tests
It refers to intrinsic propensity of the host tissue, the tooth, to be affected by the 
carious process. It uses saliva as a diagnostic tool in detection and progression of 
dental caries. Saliva used for caries susceptibility measurement can be explained in 
four parts:
1. Bacterial count measurement (salivary microbiomics)
2. Colorimetric methods
3. Enzymatic biomarkers
4. Physical property of saliva
5. Bacterial count measurement
5.1 Sampling oral microbial community through saliva (salivary microbiomics)
When considering the hard tissue diseases in oral cavity (dental caries), sam-
pling from the acquired pellicle (AP) provides more sensitive and precise protein 
profile compared to that of saliva [7–10]. Here saliva plays like carrier of the disease 
biomarkers.
Only few fractions of known proteins found in human saliva (130/2290 pro-
teins), which are originated from acquired pellicle on dental enamel. The exact 
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biological functions of 51% of known proteins are unknown [8]. This lack of 
knowledge will provide a new vista to further research.
The particular species of microbial community grow on the AP which is 
specific to individual oral disease. The quality and quantification of these species 
can provide a clearer picture on diagnosis and find out the severity of the oral 
disease.
For example, patients exhibiting dental caries demonstrates dominated acido-
genic and acid-tolerant Gram-positive bacteria (i.e., Streptococcus and  
Lactobacilli sp) [11].
Some of the salivary determinant tests are as follows
1. Lactobacillus colony count test: assessment of the number of acidogenic bacte-
ria can be done by calculating the number of colonies appearing on Tomato 
peptone agar plates (pH 5.0) after inoculation with a sample of saliva.
2. Streptococcus mutans level in saliva: this measures the number of S. mutans 
colony forming units per unit volume of saliva.
3. Saliva/tongue blade method: estimation of the number of S. mutans in Mutans 
Salivarius Bacitracin (MSB) agar inoculated by paraffin-stimulated saliva/
Saliva-contaminated wooden spatulas [12].
5.2 Colorimetric methods
1. Snyder’s test [7, 13]: the caries susceptibility is correlated with production 
of acid that is assumed to result due to the fermentation of specific amount 
of glucose by cariogenic Lactobacillus species by inoculating saliva into agar 
containing bromocresol green indicator.
2. Albans test: this is a simpler version of Snyder’s test in which the patient 
expectorates directly into tubes that contain the medium. In this test, some-
what softer medium is used that permits the transmission of saliva and acids 
without the requirement of melting the medium [7].
3. Swab test: the principle of this test is same as that of Snyder’s test i.e., capacity 
of salivary microorganism to form organic acids from a specific carbohydrate 
medium. The medium encompasses a colour changing indicator dye, bromo-
cresol, which changes its colour when the environment changes its Ph.
5.3 Enzymatic biomarkers
1. Salivary reductase test: this test quantifies the activity of the reductase enzyme 
present in salivary bacteria.
2. Peroxidase: peroxidase is a salivary enzyme which neutralises the toxic com-
pound (hydrogen peroxide) produced by oral microorganisms and reduces 
production of acid in the dental plaque. This severely reduces the plaque 
accumulation thereby reduces the plaque related diseases like dental caries and 
periodontal diseases [14].
3. Collagenase: it represents in extracellular fluids like serum or saliva represents 
tissue destruction or cell death. In saliva it indicates destruction of pulp (severe 
dental caries) or destruction of periodontal tissue [15].
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6. Physical properties of saliva
1. Salivary buffer capacity test:
a. This test measures the amount of millilitres of acid involved in lowering the Ph 
of saliva via an arbitrary Ph interval, such as, from Ph 7.0 to 6.0 or the quantity 
of acid or base essential to bring colour indicators to their end point [16].
b. Population level researches salivary flow rate and buffer effect show a 
contrary correlation with caries susceptibility [17].
2. Flow rate:
Many researches showed that, higher the flow rate showed quicker is the 
salivary clearance [17–19] and greater is the buffer capacity [18] Reduced 
salivary flow rate and the associated reduction of oral defence systems may 
cause severe caries and mucosal inflammations [16, 17, 20].
7. Salivary ions
Calcium ion is the most extensively researched salivary ion for dental caries and 
periodontal disease. Demineralisation of teeth or bone leads to leach out excess of 
calcium ion into saliva. Increased levels of salivary calcium ion indicate the presence 
and severity of oral diseases. Similarly increased selenium content in saliva and 
food is the indicative of dental caries in subjects [21].
8. Periodontal disease and saliva
Diagnosing active phases of periodontal diseases, and identifying those at risk for 
active disease has been challenging for both clinicians and investigators. Since saliva 
can be easily collected which contains the locally derived and systemically derived 
markers of periodontal disease, it can provide specific diagnostic test for periodontitis.
Enzymes present in saliva are contributed by the cells of the salivary glands, oral 
microorganisms, PMNs, epithelial cells and GCF entering the oral cavity. Studies 
have shown a reliable relationship between enzyme activity and periodontal status 
and its response to the periodontal treatment.
Saliva can be categorised in to two types, whole saliva and saliva from specific 
glands [22–24]. Differences in the amount of fluid and constituents of each gland 
can be determined in gland specific saliva.
Whole saliva which consists of oral fluids, secretions from the major and minor 
salivary glands, non-salivary constituents, GCF, bronchial secretions, serum, blood 
cells, food debris and microorganisms along with their products can also be used as 
a diagnostic tool.
It has been found that, proposed markers for diseases such as proteins of host 
origin (i.e., enzymes, Ig), phenotypic markers such as epithelial keratins, host cells, 
hormones, microorganisms, volatile compounds and ions are found in saliva [25].
Some of the major salivary biomarkers are discussed below:
1. Salivary proteins:
Salivary proteins are formed from combined Direction of DNA and RNAs. Any 
disparity in DNA or RNA stands can lead to altered protein formation which leads 
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to disease condition and the altered protein becomes the marker of that disease. 
A patient’s salivary protein mapping can provide details on entire body’s health 
because saliva is an exudate of blood and contains juices from gingival crevicular 
fluid along with major and minor salivary glands, and is much less invasive and more 
acceptable to the patients compared to blood sampling [10, 26–28] Salivary proteins 
play a major role in adhesion of microbes on tooth surface through AP formation 
by stereo-specific mechanism [10, 29]. Salivary proteins can regulate adherence of 
microorganism by using the carboxylterminal of histatin and of acidic proline-rich 
proteins (PRPs) by promoting or reducing the attachment to the protein [30–32].
Some of the proteins involved are
A. Enzymes:
a. Lysozyme
b. Peroxidase
c. Collagenase
d. Acidic and alkaline phosphatase
B. Glycoproteins and proline rich proteins
a. Dextran
b. Acquired pellicle forming proteins
c. Lactic acid and pyruvic acid
d. Fibronectin
C. Hormones
D. Histatin
E. Matrix metallo proteins
F. Other proteins
a. Cystatin
b. Amino acids
c. Growth factors and vascular endothelial growth factors
A. Salivary enzymes:
a. Lysozyme: lysozyme is an antimicrobial enzyme secreted in human saliva with 
the ability to hydrolase the 1,4-beta-linkages between N-acetylmuramic acid 
and N-acetyl-d-glucosamine existing in peptidoglycan, which is the major 
component of Gram-positive cell wall. Patients with low levels of lysozyme in 
saliva are more vulnerable to accumulation of dental plaque, which is con-
sidered a risk factor for oral disease and increased salivary lysozyme activity 
indicates recent infection in oral cavity [33].
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b. Peroxidase: it inhibits the hydrogen peroxide formation by microbes and there 
by prevents accumulation of plaque formation. This directly stops the plaque 
related oral diseases like periodontitis and dental caries. Quantification of this 
enzyme directly proportional to the severity of the disease status [14].
c. Collagenase: collagenase is also known to as MMP-13, is collagenolytic MMP 
with remarkably extensive substrate specificity. Presence of this in extracel-
lular fluid like serum and saliva indicate tissue destruction or cell death. In 
saliva this may indicate destruction of periodontal tissue, pulp tissue, infective 
necrosis or carcinogenic destructions [15].
d. Acid and alkaline phosphatase: the enzyme alkaline phosphatase (ALP) and 
acid phosphatase (ACP) are the twin counterpart enzymes which occur in 
many organisms ranging from bacteria to man, basically functions by cata-
lysing or blocking the hydrolysis of monoesters of phosphoric acid and also 
catalyse or block a trans-phosphorylation reaction in the presence of large 
concentrations of phosphate acceptors [34]. Some researches conveyed ampli-
fied activity of acid phosphatase and alkaline phosphatase in the acute stage of 
periodontal disease, and also observed recovery of enzyme level to the normal 
range after periodontal therapy [35, 36].
B. Glycoproteins and proline rich proteins:
a. Dextran: dextran is a complex, branched glucan (polysaccharide made of many 
glucose molecules) composed of chains of varying lengths which helps the 
plaque to attach to the host tissue. Measuring the level of salivary dextran level 
can helps in calculating the plaque attachment status. There by calculating the 
plaque related diseases quantitatively [37].
b. Acquired pellicle forming proteins: salivary proteins play a chief role in bonding 
of microbes on tooth surface through acquired pellicle formation by stereo-
specific mechanism [29]. These salivary proteins decide the type of microbes 
to grow. Hence identifying these proteins which are specific to grow selective 
bacteria will provide knowledge about the type of disease.
c. Fibronectin: fibronectin is a glycoprotein that mediates adhesion between cells 
and encourages selective adhesion and colonisation of certain favourable 
bacterial species. It also involved in inflammation, chemotaxis, and wound 
healing and tissue repair [23, 38]. Quantification of fibronectin in saliva 
provides a clear picture on periodontal disease status.
C. Hormones:
Cortisol: cortisol is a hormone highly sensitive to emotional changes and is stress 
related. It provides anti-inflammatory and immunosuppressive effect. This has 
direct effect on oral infection and dental plaque related illness [38, 39]. Even though 
lots of researches indicate the relation of cortisol and oral diseases, more specific 
and confirmatory researches are needed.
D. Histatin:
Histatin is a salivary protein secreted from parotid and submandibular 
glands with definite antimicrobial properties. It interacts with endotoxic 
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lipopolysaccharides situated in the membrane of Gram-negative bacteria and 
neutralises it. It also has antihistaminic action, hence influences oral inflamma-
tion [38, 40, 41].
E. Matrix metallo proteins:
They are host proteinases accountable for both tissue degradation and remodel-
ling. The presence of these metallo proteins indicates tissue destruction. MMP 
8 is the most predominant MMP found in ill periodontal tissue and GCF. Recent 
researches reviled that the level of MMP-8 was highly raised in saliva of patients 
with periodontal disease [38, 42].
F. Other proteins:
a. Cystatin: this is a proteolytic enzyme produced by pathogenic bacteria, inflam-
matory cells, fibroblasts and osteoclasts which have collagenolytic property. It 
helps in spreading of oral disease to different planes also progress the disease 
status [23, 38]. Measuring the level in saliva can explain the severity of the oral 
diseases like periodontal disease and potentially malignant disease.
b. Amino acids: some of the amino acids like Proline shows increased levels in 
saliva of periodontally ill subjects compared to the healthy individuals. This 
may be due to degradation of salivary proteins by bacterial activities [38, 43, 
44]. Presence of proline in saliva directly proportional to the level of bacteria 
in dental plaque. Hence it quantifies the plaque related oral diseases.
c. Growth factors and vascular endothelial growth factors: these are angiogenic 
cytokines associated with inflammation and healing tissue. Higher level of 
these proteins in saliva observed in the inflammatory conditions (periodontal 
diseases) or growth of tumour (Malignant tumours) [23, 38].
G. Human salivary immune system:
a. Immunoglobulins: immunoglobulins are specific first-line defence mechanism 
of saliva. The chief immunoglobulin in saliva is secretory IgA (sIgA), which is 
produced by the plasma cells in the salivary glands. IgA has 2 subclasses, IgA1 
which is predominated in serum and IgA2, which is predominantly present in 
secretions like saliva, milk and sweats [38, 45]. Many researches show the posi-
tive correlation between severity of inflammation (Periodontal disease) and 
IgA concentration [14, 46].
b. Salivary neutrophil count: neutrophils play a major role in the innate immune 
response. Most of the oral diseases are associated with infection and inflam-
mations, which are explained in the form of neutrophil count in saliva. Very 
meagre research directed to correlate the neutrophils in plaque, saliva, and 
gingival crevicular fluid (GCF) to periodontally healthy and diseased subjects. 
These researches reviled that there is positive correlation between oral diseases 
with PMN counts [47–49].
H. Salivary ions:
Calcium ion in saliva indicates demineralization of teeth or alveolar bone which 
leaches out into saliva indicating severity of dental and periodontal diseases [21].
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I. Oxidative stress assessment:
Redox (reduction and oxidation) reactions are common in all cells. But imbalance 
between reduction and oxidation process can lead to oxidative stress within the cell 
which destroys the cell. Oxidative stress was involved in the progression of periodontal 
diseases [50–52]. In chronic periodontitis, there was lower serum total antioxidant 
level when equated to the control individuals [52, 53] Biomarkers of lipid peroxidation 
(one of the oxidative stress-mediated pathways) such as 8-isoprostane and malondial-
dehyde (MDA) were elevated in patients with chronic periodontitis [52, 54–56].
J. Salivary Microbiomics:
The particular species of microbial community grow on the AP which is spe-
cific to individual oral disease. The quality and quantification of these species can 
provide a clearer picture on diagnosis and find out the severity of the oral disease. 
Patients with periodontal disease Express increased percentage of obligately 
anaerobic bacteria (i.e., Gram-negative species) [10, 57].
Some of the literatures on salivary biomarkers to detect periodontal diseases are 
as follows:
9. Oral cancer and saliva
Oral cancer is 6th most common human malignancies with approximately 50% 
mortality rate in 5 years. Oral cancer is a potentially lethal disease and the result of 
Author (year) Biomarkers Inference
Nakamura and 
Slots (1983) [35]
Salivary enzymes Significant difference between diseases and 
healthy periodontium.
No significant difference between LJP 
and AP
Zambon et al. 
(1985) [58]
levels of caprylate esterase lipase, leucine, 
valine and cysteine aminopeptidases, 
trypsin, B-galactosidase, B-glucuronidase 
and B-glucosidase, sub gingival black 
pigmented bacteroides and motile organisms
A decrease was seen in the levels of all the 
biomarkers after the treatment in AP
Gregory et al. 
(1992) [59]
Immunoglobulins Igs in LPJ patients was higher than healthy 
individuals of same age, race and gender
Gibbons et al. 
(1986) [30]
Fibronectin-degrading enzymes in saliva This biomarker was higher in concentration 
in diseased patients
Nieminem et al. 
(1993) [60]
Protease levels Decrease in the levels of protease 
markers after the treatment in advanced 
periodontitis
Ingman et al. 
1993 [61]
Collagenase, elastase like and trypsin like 
activity
AP patients’ saliva demonstrated a higher level 
of protease, collagenase and elastase lie activity 
when compared to LJP and healthy patients
Uitto et al. 
(1990) [62]
Collagenase Higher in periodontitis patients
Orner 1976 [63]
Halinen et al. 
1996 [64]
Collagenase, activated matrix 
metalloproteinase
Higher in children with Down’s syndrome 
who are more prone to periodontal diseases
Hayakawa 
et al.1994 [65]
TIMP-1 and total collagenase activity TIMP-1 was lower in patients with 
periodontal disease and total collagenase 
activity was higher in diseased patients
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the treatment and prognosis largely determined by primary diagnosis. For preven-
tion, treatment and for prognosis, it is essential to measure the disease objectively 
and accurately in quantitative manner. Quantification of biochemical or molecular 
specific products of cancers in serum or localised body juices can be one of the current 
methods of measuring oral cancer objectively. Salivary diagnostics has influenced 
several researchers and has been verified as an important tool in the diagnosis of 
many systemic conditions and prognosis of the disease. Developments in the ground 
of molecular biology, salivary genomics and proteomics have directed to the detection 
of novel molecular markers for oral cancer diagnosis, therapeutics and prognosis.
Several research groups have found that salivary levels of specific proteins 
are increased in whole saliva of patients with oral squamous cell carcinoma. For 
example, CD44 (a cell surface glycoprotein involved in cell-to-cell interaction),  
44 Cyfra 21-1 (a fragment of cytokeratin 19), tissue polypeptide antigen (TPS),  
and cancer antigen 125 (CA-125) have been suggested as oral cancer bio 
markers [2, 66].
Abundant biomarkers have been studied for finding of oral potentially malig-
nant diseases and cancer, until now no further research has been done. Whole 
saliva was used to conduct most of the research projects. Whole saliva comprises 
of juices from all major and minor salivary glands, as well as liquids from mucosal 
and periodontal tissues, which are influenced by oral and systemic environments 
and by host immune responses and carry the essence of disease product with them. 
Measuring the levels of disease product will provide a specific diagnostic and prog-
nostic value. Additionally, least requirement of money, material and manpower 
makes it more economical, less time consumption, and no special training make 
this methodology easily accepted.
10. Usage of stimulated or un-stimulated saliva for collection
Unstimulated saliva is considered as an ideal sample because it has no effect on 
flow rate and salivary composition of salivary glands. But some researches shows 
that stimulated saliva also can provide equally or more precise detection of cancer 
biomarkers [67, 68]. Limited researches were performed in these directions on 
the effect of stimulated and unstimulated saliva on salivary biomarkers of cancer. 
Hence, it needs to be studied to further standardise the salivary biomarkers.
11. Storage and transportation of saliva
Saliva is very sensitive sample, which is influenced by systemic, physiological, 
microbial, environmental (food products) and biochemical changes in oral cavity. It 
also fluctuates with time of collection, Ph of the surrounding environment, temper-
ature type of saliva collection method, and storage methods [69, 70–73] Some study 
reported that storage at −80°C provides less biochemical and microbial changes in 
saliva hence gives better results as compared to −20°C [72] . To avoid altered results, 
there should be least time gap between sample collection and analysis.
12. Classification of salivary biomarkers for oral cancer
Biomarkers have been classified based on biomolecules and disease states [74, 75].
Based on biological molecules:
1. DNA biomarkers
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2. RNA biomarkers
3. Protein biomarkers
a. Enzymes
b. Hormones
c. Glycoproteins
4. Salivary ions
5. Oxidative stress assessment
i. Based on disease state
1. Diagnostic biomarkers
2. Prognostic biomarkers
More than 100 potential salivary biomarkers have been reported till date, they 
can be explained with following headings:
1. Peptides
2. Proteins
3. DNA
4. Salivary mRNA
1. Peptides: some of the researches explain that polypeptides like defensin which 
possess cytotoxic and antimicrobial properties, which exhibits their presence in 
azurophil granules of polymorphonuclear leukocytes is one of the potent bio-
marker of oral cancer. OSCC can be distinguished even in their earlier stages by the 
raised levels of salivary defensin-1 matched with healthy controls [67, 76].
2. Proteins: major portion of salivary biomarkers are protein in nature. Most of the 
proteins share their presence with other diseases or environmental factors (food), 
this exhibits higher levels of sensitivity with low specificity. Some of the protein 
biomarkers showed significant elevated level in saliva such as interleukins (8, 6, 
1b), matrix metalloproteinase (MMP 2, 9), transforming growth factor (TGF-1), 
Ki67, cyclic D1, transferrin, amylase, tumour necrosis factor (TNF-a) and catalase 
among saliva of oral squamous cell carcinoma by various studies [77]. Protein CD44 
showed elevated levels in saliva (oral rinse) of oral squamous cell carcinoma patients 
(n = 102) matched to controls (n = 69) [78]. some of the researches confirmed that 
IL-8 and IL-6 are informative biomarkers for OSCC, where IL-8 and IL6 showed 
elevated levels of concentration in saliva and serum respectively [79].
A. Enzymes:
1. Lysozyme: lysozyme is an antimicrobial enzyme secreted in human saliva with 
the capability to hydrolase peptidoglycan, which is the major constituent 
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of Gram-positive cell wall. Lysozyme shows antitumor properties by direct 
activation of immune cells or it can raise tumour cell immunogenicity. And 
also, lysozyme can release elements from bacteria (peptidoglycans and/
or polyribopyrimidinic acids) responsible for immune-potentiation and 
therefore antitumor activity [80].
2. Pyruvate kinase M2 isoenzymes: cancer cell uses metabolic alteration 
(Warberg’s effect) for their survival and growth. They chose anaerobic 
respiration for their energy needs even though abundant availability of 
oxygen. Pyruvate kinase muscle iso-enzyme M2 (PKM2) is a glycolytic 
enzyme and a vital enzyme in tumour cell metabolism and growth. 
Increased level in serum and saliva indicate presence of malignancy [81].
3. Collagenase: collagenase is the major intracellular enzyme explains the 
destruction of the tissue if found in extracellular fluids like saliva. In saliva 
this may indicate destruction of periodontal tissue, pulp tissue, infective 
necrosis or carcinogenic destructions [15].
4. Acid and alkaline phosphatase: a study clarifies that the salivary ALP 
enzyme displays significantly higher levels in subjects with diabetes mel-
litus, smokers and subjects with potentially malignant disorders without 
any periodontitis associated to systemically healthy persons [82]
B. Glycoproteins:
Lactic acid and pyruvic acid: pyruvic acid and lactic acids were produced as the 
end product in the physiologic process of glycolysis [83, 84]. This energy crea-
tion cascade carry on by using the end product (pyruvate) of glycolysis as a fuel 
to Krebs cycle in mitochondria by oxidative phosphorylation. But this process 
gets interrupted in malignant cells where cell undergoes fermentation of sugar 
molecule (anaerobic respiration) even though enough presence of oxygen. This 
process is known as Warberg’s effect. This leads to accumulation of the excess 
PA and LA. Hence quantification can give a clearer picture on the stages of 
cancer [83].
C. Salivary ions: most of the researches explain excess and deficient levels of 
copper or zinc were significant correlation with oral cancer risk [85]
D. Oxidative stress assessment: oxidative stress is the product of a discrepancy 
between oxidant factors and protective antioxidant systems; it may occur 
due to an excess of free radicals, or by the shrinking of the antioxidant 
systems.
Oxidative stress was also associated with oral cancer, as amplified lipid 
peroxidation and reduced antioxidants was reported in patients suffering 
from stage II, III, and IV oral cancer [52, 86].
3. DNA: DNA is highly specific type of biomarker used for detection of cancer. 
It requires high end operating machineries and also requires special training 
to operate it. This makes it more expensive biomarker to detect. Boyle et al. 
observed that OSCC exhibits p53 mutations in 71% of saliva samples by using 
plaque hybridization technique [87]. Aberrant methylation of p16, MGMT and 
DAP-K in OSCC patients was recognised by Rosas et al.
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4. Salivary mRNAs: oral carcinogenesis can be detected by measuring the elevated 
six mRNA molecules such as DUSP1, H3F3A, IL 1B, IL 8, SAT and S100 [88].
a. DUSP1 (dual specificity phosphatase 1): DUSP mRNA involved in protein 
modification, oxidative stress, and signal transduction and participates 
in MAPK (Mitogen Activated Protein Kinase) pathway. Molecular stud-
ies showed that the carcinogenesis is associated with hypermethylation of 
DUSP1 gene [89].
b. H3F3A: these proteins are nuclear proteins, located in chromosome 1, 
responsible for the structural integrity of chromosomal nucleosome and acts 
as a one of the proliferative marker for oral cancer.
c. IL IB: Interleukin 1 beta is a chemical mediator of cell proliferation, dif-
ferentiation, and apoptosis and also inflammation. Though it represents its 
presence in other pathological and physiological aspects, it shows Elevated 
serum levels in patients with oral squamous cell carcinoma.
d. IL 8: Interleukin 8 (neutrophil chemotactic factor) is a pro-inflammatory 
cytokine which plays a key role in tumour angiogenesis, cell adhesion, and cell 
cycle arrest. By observing various studies on salivary biomarkers, it concluded 
that IL 8 in saliva is the best biomarker for squamous cell carcinoma [79].
e. SAT: Spermidine/spermine N1-acetyltransferase 1 a protein that partici-
pates in the catabolism of polyamines. Researches show elevated levels of 
SAT in the saliva of oral cancer patients compared to the healthy controls.
f. S100 P: it is a calcium binding protein P, which is located in the cytoplasm or 
in the nucleus. Its levels in saliva get deviated among oral cancer subjects.
5. Salivary microRNA: MicroRNAs (miRNAs) are short parts of RNA transcripts. 
They are associated with most of the cellular functions like cell growth, 
apoptosis, differentiation, motility, and immunity. miRNAs are more specific 
and potent compared to mRNAs. They exhibit high sensitivity which effec-
tively detect and differentiate poorly differentiated carcinomas. Some of these 
include miR-125a, miR-200a and miR-31 [88].
13. Conclusion
Saliva contains numerous substances which are potential biomarker of many 
oral diseases. Saliva could be a key cause of biochemical records capable of 
identifying some diseases. Hence would be useful for ideal methods to diagnosis, 
prognosis, and monitoring and management of patients with oral diseases. Even 
though saliva provides some evidence in early detection of oral diseases with 
advantages like easy, inexpensive, safe, less time and technique sensitive and non-
invasive approach over serum, it showed resistance in the diagnostic and clinical 
usage. Salivary diagnostics faces lots of challenges for the use of saliva-based oral 
fluid diagnostics for future application. Salivary diagnostic procedures required 
more sensitive technological support and quality researches to generalise and 
implement the procedures.
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